跳至主要内容
临床试验/ACTRN12620001311943
ACTRN12620001311943招募中3 期

Palmitoylethanolamide and polydatin effect on pain and dysmenorrhea in women scheduled for laparoscopic treatment of possible endometriosis: a double blind randomised controlled trial.

The University of Melbourne0 个研究点目标入组 260 人开始时间: 2020年12月7日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • Women aged 18 – 45 with pelvic pain scheduled for laparoscopic treatment of possible endometriosis. Both women with and without previous evidence of endometriosis on ultrasound or previous surgery are eligible
  • - Women who agree to use any type of contraception and avoid conceiving during the 8-week treatment phase.
  • - English speakers

排除标准

  • Pregnancy or actively trying to conceive
  • Breastfeeding
  • Previous hysterectomy
  • Suspected malignancy
  • Inability to provide informed consent

研究者

相似试验

Palmitoylethanolamide and polydatin effect on pain... | 临床试验